Medindia

X

After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019

Thursday, August 5, 2010 Drug News J E 4
Advertisement
The Launch of Depot Formulations of Atypical Antipsychotics Will Partially Offset Losses in the Market, According to Findings from Decision Resources

For more information, contact:

Decision Resources, Inc.

Lisa Osgood

781-296-2606

losgood@hl-isy.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
How Local Governments Are Addressing Retiree Healt...
S
Natural Products Expo East Returns to Baltimore fo...